A biotech company for the efficient analysis of DNA damage
We develop equipment, carry out research projects and offer services and training courses.
At the heart of our technology is the comet assay, which has potential as a diagnostic tool in personalized medicine and is already widely used in human bio-monitoring and for industrial testing of chemicals including nano- and advanced materials and drugs.
We have developed a high throughput, integrated, user-friendly DNA damage testing facility. Hospitals, research labs, chemical and pharma industries and regulators form our present and future customer base.
Examples of projects – explore more in our projects section
- EU-funded project NANO2FILM “Targeted multiplexed lipid nanocarriers against drug-resistant bacterial bioFILM” (NANO2FILM): We are contributing with our expertise in safety assessment of innovative class of nanomedicine (2025-2028)
- Marie Sklodowska-Curie Doctoral Network Project ‘NANAQUA’: Nanotechnology-enabled water treatment / NorGenoTech is WP leader and PhD promoter (2025-2029)
- Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE) project ‘CompSafeNano’: NanoInformatics Approaches for Safe-by-Design / NorGenoTech is WP leader (2022-2026)
- Industrial PhD project ‘DNA damage in blood cells in relation to chemotherapy and nutritional status in colorectal cancer patients’ / PhD supervisor, Project Manager
- EEA and Norway Grants project TEPCAN ‘Theranostic Exosomes in Personalized Cancer Nanomedicine’ (Project No. TEPCAN/0057/2019-00) / NorGenoTech is Project partner
Examples of products – explore our products
